Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

Albuterol Sulfate

(Ventolin/Proventil)

 

GCEMS Protocols:

  • multiple

 

INDICATIONS:

 

  • Acute bronchospasm
  • Cardiac arrest associated with asthma

 

DOSAGE:

 

ADULT:

 

    • 5 mg via handheld nebulizer or nebulizer mask; may repeat once for a total of 10 mg

 

PEDIATRIC:

 

  • 2.5 mg via handheld nebulizer or nebulizer mask; may repeat once for a total of 5 mg

 

  • Requires OLMC for EMT to repeat dose

 

CONTRAINDICATIONS:

 

  • Hypersensitivity to any of the contents of the inhalation solution

 

SIDE EFFECTS:

  • Tremor; Dizziness; Nervousness; Headache; Nausea; Tachycardia; Bronchospasm